FLT4, Recombinant, Human, aa25-774, His-Tag (Vascular endothelial growth factor receptor 3, Fms-like tyrosine kinase 4, Tyrosine-protein kinase receptor FLT4)

Catalog No : USB-169973
471.28€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name FLT4, Recombinant, Human, aa25-774, His-Tag (Vascular endothelial growth factor receptor 3, Fms-like tyrosine kinase 4, Tyrosine-protein kinase receptor FLT4)
Catalog No USB-169973
Supplier’s Catalog No 169973
Supplier US Biologicals
Source antigen Recombinant, Insect cells
Reactivity
Cross reactivity
Applications
Molecular weight 120
Storage -20°C
Other names
Grade Highly Purified
Purity ~90% (SDS-PAGE, HPLC)
Form Supplied as a lyophilized powder with no additives. Reconstitute with sterile dH2O to 0.1mg/ml.
Reactivity life 12 months
Note For reserch purpose only
Purity ~90% (SDS-PAGE, HPLC)
Description The Flt-4 gene is widely expressed in the early embryo but becomes restricted to the lymphatic endothelial a latter stages of development. It is important for lymphangiogenesis. Both VEGF family members VEGF-C and VEGF-D have been shown to bind and activate VEGFR-3/FLT-4. Soluble FLT4 Human Recombinant fused with a carboxy-terminal 6X histidine-tag produced in baculovirus is a monomeric, glycosylated, polypeptide containing the extracellular part, 25-774 amino acids and having a total molecular mass of 120kD. The soluble receptor protein contains only the first 7 extracellular domains, which contain all the information necessary for ligand binding.The FLT4 is purified by proprietary chromatographic techniques. Source: Recombinant protein corresponding to aa25-774 from human FLT4, fused to 6X His-tag at C-terminus, expressed in insect cells. Molecular Weight: ~120kD Biological Activity: Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human VEGFR-3/FLT-4 at 5ug/ml can bind recombinant rat VEGF-C in a linear range of 8-500ng/ml. Endotoxin: <0.1ng/ug Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile dH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.